• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 204-218 of 276 results

1062 Exhibit: Exhibit 1062 Appendix B to Exhibit 1032

Document IPR2017-01434, No. 1062 Exhibit - Exhibit 1062 Appendix B to Exhibit 1032 (P.T.A.B. Jun. 5, 2018)

cite Cite Document

1036 Exhibit: Alm A, ¿¿¿Latanoprost in the treatment of glaucoma,¿¿¿ Clin Ophthalmo...

Document IPR2017-01434, No. 1036 Exhibit - Alm A, ¿¿¿Latanoprost in the treatment of glaucoma,¿¿¿ Clin Ophthalmol, 81967¿¿¿85 2014 (P.T.A.B. Jun. 5, 2018)

cite Cite Document

1052 Exhibit: Latanoprost DrugBank Profile, available at httpswwwdrugbankcadrug...

Document IPR2017-01434, No. 1052 Exhibit - Latanoprost DrugBank Profile, available at httpswwwdrugbankcadrugsDB00654 last visited May 31, 2018 (P.T.A.B. Jun. 5, 2018)

cite Cite Document

2032 Exhibit: Ex2032 Zioptan Label

Document IPR2017-01434, No. 2032 Exhibit - Ex2032 Zioptan Label (P.T.A.B. Mar. 5, 2018)

cite Cite Document

1038 Exhibit: Mishima, Hiromu K, et al, ¿¿¿Circadian Intraocular Pressure Managem...

Document IPR2017-01434, No. 1038 Exhibit - Mishima, Hiromu K, et al, ¿¿¿Circadian Intraocular Pressure Management with Latanoprost Diurnal and Nocturnal Intraocular Pressure Reduction and Increase...

cite Cite Document

2052 Exhibit: Ex 2052 CA Federal Court link to Alcon Canada v Apotex

Document IPR2017-01434, No. 2052 Exhibit - Ex 2052 CA Federal Court link to Alcon Canada v Apotex (P.T.A.B. Aug. 9, 2018)

cite Cite Document

1033 Exhibit: Kerstetter, JR et al, ¿¿¿Prostaglandin F2¿¿ 1 Isopropylester Lowers Intr...

Document IPR2017-01434, No. 1033 Exhibit - Kerstetter, JR et al, ¿¿¿Prostaglandin F2¿¿ 1 Isopropylester Lowers Intraocular Pressure Without Decreasing Aqueous Humor Flow,¿¿¿ American Journal of Ophth...

cite Cite Document

1039 Exhibit: Camras et al, ¿¿¿Latanoprost, a Prostaglandin Analog, for Glaucoma T...

Document IPR2017-01434, No. 1039 Exhibit - Camras et al, ¿¿¿Latanoprost, a Prostaglandin Analog, for Glaucoma Therapy efficacy and safety after 1 year of treatment in 198 patients,¿¿¿ Ophthalmology, 10...

cite Cite Document

1041 Exhibit: Konstas, Anatasios G P et al ¿¿¿Twenty four hour efficacy with preserv...

Document IPR2017-01434, No. 1041 Exhibit - Konstas, Anatasios G P et al ¿¿¿Twenty four hour efficacy with preservative free tafluprost compared with latanoprost in patients with primary open angle glauco...

cite Cite Document

1040 Exhibit: Camras CB et al, ¿¿¿Comparison of latanoprost and timolol in patients ...

Document IPR2017-01434, No. 1040 Exhibit - Camras CB et al, ¿¿¿Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma a six month, masked, multicenter trial in the Unite...

cite Cite Document

1042 Exhibit: Ikeda, Yoko et al ¿¿¿Comparison study of intraocular pressure reductio...

Document IPR2017-01434, No. 1042 Exhibit - Ikeda, Yoko et al ¿¿¿Comparison study of intraocular pressure reduction efficacy and safety between latanoprost and tafluprost in Japanese with normal tensio...

cite Cite Document

1034 Exhibit: Villumsen, Jorgen et al, ¿¿¿Prostaglandin F2¿¿ isopropylester eye drop...

Document IPR2017-01434, No. 1034 Exhibit - Villumsen, Jorgen et al, ¿¿¿Prostaglandin F2¿¿ isopropylester eye drops effect on intraocular pressure in open angle glaucoma,¿¿¿ Br J Opthalmol 73975¿¿¿979 19...

cite Cite Document

2033 Exhibit: Ex2033 Ueno Japan PO Translation

Document IPR2017-01434, No. 2033 Exhibit - Ex2033 Ueno Japan PO Translation (P.T.A.B. Mar. 5, 2018)

cite Cite Document

1061 Exhibit: Exhibit 1061 US Patent No 4,599,353 to Bito LZ 1986

Document IPR2017-01434, No. 1061 Exhibit - Exhibit 1061 US Patent No 4,599,353 to Bito LZ 1986 (P.T.A.B. Jun. 5, 2018)

cite Cite Document

2025 Exhibit: Ex2025 deLong Transcript

Document IPR2017-01434, No. 2025 Exhibit - Ex2025 deLong Transcript (P.T.A.B. Mar. 5, 2018)

cite Cite Document
<< 1 2 3 4 5 ... 14 15 16 17 18 19 >>